Juvenile and adult-onset scleroderma: Different clinical phenotypes
Authors:
- 29 March 2023
- journal article
- research article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 60, 152197
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the Rheumatic Diseases, 2010
- Characteristics of Patients with Juvenile Onset Systemic Sclerosis in an Adult Single-center CohortThe Journal of Rheumatology, 2010
- Incidence of childhood linear scleroderma and systemic sclerosis in the UK and IrelandArthritis Care & Research, 2010
- EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)Annals of the Rheumatic Diseases, 2009
- Factors affecting survival in juvenile systemic sclerosisRheumatology, 2008
- Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti–topoisomerase I antibodyArthritis & Rheumatism, 2007
- Localized sclerodermaCurrent Opinion in Rheumatology, 2006
- Angiographically proven coronary artery disease in sclerodermaRheumatology, 2006
- Accelerated Atherosclerosis in Autoimmune Rheumatic DiseasesCirculation, 2005
- Localized scleroderma in childhood is not just a skin diseaseArthritis & Rheumatism, 2005